Gadoxetic acid-enhanced MR imaging is an essential modality for the screening and assessment of hepatic diseases, which has an incremental value when combined with contrast-enhanced computed tomography for detecting colorectal liver metastasis (CLM). We assessed the diagnostic performance of an abbreviated protocol (axial heavily T2-weighted + axial and reconstructed-coronal hepatobiliary phase + axial diffusion-weighted imaging) compared with the standard routine clinical one for CLM screening. Our results demonstrated excellent performance for the detection of CLM comparable to standard one less than one third of acquisition time.
This abstract and the presentation materials are available to members only; a login is required.